The U.S. Takes the Fight Against Bribery to Foreign Officials
American companies, U.S. issuers, and persons in the United States have long been barred from bribing foreign officials under the Foreign Corrupt Practices Act (FCPA). But until December 2023, no U.S. law directly penalized those foreign officials for soliciting or taking bribes. With the enactment of the Foreign Extortion Prevention Act (FEPA), buried deep within…
Continue ReadingTransnational Whistleblower Litigation
American corporate fraud has long captured the international imagination. Ask people around the globe whether they have heard of Enron, Lehman Brothers, or the Madoff Ponzi scheme, and it’s likely the answer will be yes. The scale and consequences of these three cases alone often lead people to assume that the biggest frauds of our…
Continue ReadingThe Role of the FCPA in Transnational Litigation
Professor Maggie Gardner’s thought-provoking post on the role of the UN Convention Against Corruption (UNCAC) in forum non conveniens analysis in IMSS v. Stryker and IMSS v. Zimmer Biomet Holdings led me to consider how the Foreign Corrupt Practices Act (FCPA) factors into these cases. Interestingly, both defendant corporations, Stryker Corporation and Zimmer Biomet Holdings,…
Continue Reading